ECSP993117A - DERIVATIVES OF QUINOLIN -2 - ONA USEFUL AS AGENTS AGAINST CANCER - Google Patents

DERIVATIVES OF QUINOLIN -2 - ONA USEFUL AS AGENTS AGAINST CANCER

Info

Publication number
ECSP993117A
ECSP993117A ECSP993117A ECSP993117A EC SP993117 A ECSP993117 A EC SP993117A EC SP993117 A ECSP993117 A EC SP993117A EC SP993117 A ECSP993117 A EC SP993117A
Authority
EC
Ecuador
Prior art keywords
useful
ona
quinolin
derivatives
against cancer
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Joseph Peter Lyssikatos
Greca Susan Deborah La
Bingwei Vera Yang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993117 priority Critical patent/ECSP993117A/en
Publication of ECSP993117A publication Critical patent/ECSP993117A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

(gráfico), y a sus sales, profármacos y solvatos farmacéuticamente aceptables, en la que R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 y R11 son como se han definido en la presente. Los compuestos anteriores de fórmula I son útiles en el tratamiento de trastornos hiperproliferativos como cáncer en mamíferos. La invención también se refiere a composiciones farmacéuticas que contienen los compuestos de fórmula I y a procedimientos para inhibir el crecimiento celular anómalo, incluyendo cáncer, en un mamífero, administrando a dicho mamifero que requiere dicho tratamiento a los compuestos de fórmula I.(graph), and their pharmaceutically acceptable salts, prodrugs, and solvates, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, and R11 are as defined herein. The above compounds of formula I are useful in the treatment of hyperproliferative disorders such as cancer in mammals. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods for inhibiting abnormal cell growth, including cancer, in a mammal, by administering said mammal requiring such treatment to the compounds of formula I.

ECSP993117 1999-08-27 1999-08-27 DERIVATIVES OF QUINOLIN -2 - ONA USEFUL AS AGENTS AGAINST CANCER ECSP993117A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993117 ECSP993117A (en) 1999-08-27 1999-08-27 DERIVATIVES OF QUINOLIN -2 - ONA USEFUL AS AGENTS AGAINST CANCER

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993117 ECSP993117A (en) 1999-08-27 1999-08-27 DERIVATIVES OF QUINOLIN -2 - ONA USEFUL AS AGENTS AGAINST CANCER

Publications (1)

Publication Number Publication Date
ECSP993117A true ECSP993117A (en) 1999-10-06

Family

ID=42044105

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993117 ECSP993117A (en) 1999-08-27 1999-08-27 DERIVATIVES OF QUINOLIN -2 - ONA USEFUL AS AGENTS AGAINST CANCER

Country Status (1)

Country Link
EC (1) ECSP993117A (en)

Similar Documents

Publication Publication Date Title
GT199900139A (en) DERIVATIVES OF QUINOLIN-2-ONA ÙTILES AS AGENTS AGAINST CANCER.
PA8480101A1 (en) DERIVATIVES OF QUINOLIN-2-ONA ALQUINILS SUBSTITUTED USEFUL AS ANTI-TARGET AGENTS
CU23413B7 (en) NEW BENZOIMIDAZOL DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS
AR026633A1 (en) NEW BENZOIMIDAZOL DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS
UY28135A1 (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH
AR028985A1 (en) COMPOUNDS DERIVED FROM QUINOLIN-2-ONA- SUBSTITUTED WITH HETEROARILO USEFUL AS ANTI-VANEER AGENTS, PROCESSING PROCESSING OF DISEASES USING SUCH COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT
ECSP024393A (en) SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF NORMAL CELLULAR GROWTH
PA8487601A1 (en) USEFUL SUBSTITUTED BICYCLE DERIVATIVES AS AGENTS AGAINST CANCER
PA8472301A1 (en) ISOTIAZOLE DERIVATIVES USEFUL AS ANTI-CANCER AGENTS
UY27685A1 (en) INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS, AND PROCEDURES FOR USE
ECSP993117A (en) DERIVATIVES OF QUINOLIN -2 - ONA USEFUL AS AGENTS AGAINST CANCER
PA8505801A1 (en) HYGROMYCIN DERIVATIVES
PA8474401A1 (en) 3-KETO TRICYCLIC DERIVATIVES OF 6-0-METHYLERITHROMYCIN
ECSP993118A (en) DERIVATIVES OF QUINOLIN -2 -ONE ALKYNYL SUBSTITUTED USEFUL AS ANTI-CANCER AGENTS
ECSP003793A (en) NEW BENZOIMIDAZOL USEFUL DERIVATIVES AS ANTIPROLIFERATIVE AGENTS
UY26460A1 (en) NEW BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS.
AR028667A1 (en) HYGROMYCIN DERIVATIVES A
ECSP992984A (en) ISOTIAZOLE DERIVATIVES USEFUL AS ANTI-CANCER AGENTS
ECSP003347A (en) QUINOLIN DERIVATIVES - 2- ONA SUBSTITUTED WITH HETEROARILO USEFUL AS ANTI-BANERIGINAL AGENTS
ECSP993260A (en) USEFUL SUBSTITUTE BICYCLE DERIVATIVES AS AGENTS AGAINST CANCER
UY28131A1 (en) BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH
UY26421A1 (en) HYGROMYCIN DERIVATIVES
UY27557A1 (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH.
DOP2003000786A (en) BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH.
DOP2003000595A (en) INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIONIC AGENTS, AND PROCEDURES FOR USE